SCHEMBL12465812

SCHEMBL12465812

N#CC1(CNc2nc(-c3ccnc(F)c3)ccc2F)CCOCC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK9 P50750 6/20 0.35
CCNT1 O60563 5/20 0.35
MAP4K4 O95819 3/20 0.35
MINK1 Q8N4C8 3/20 0.35
TNIK Q9UKE5 3/20 0.35
MAPT P10636 2/20 0.33
TRPV3 Q8NET8 1/20 0.33
MTOR P42345 1/20 0.33
CCNK O75909 4/20 0.33
CDK14 O94921 2/20 0.33
CDK1 P06493 2/20 0.33
CCNA2 P20248 2/20 0.33
CDK2 P24941 2/20 0.33
CDK5 Q00535 2/20 0.33
CDK16 Q00536 2/20 0.33
CCNB1 P14635 1/20 0.33
CDK7 P50613 1/20 0.33
CCNH P51946 1/20 0.33
MNAT1 P51948 1/20 0.33
CDK5R1 Q15078 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10179244 0.90 CDK9 (0.40) CDK9CCNT1MAP4K4MINK1TNIK
SCHEMBL12465950 0.82 CCNT1 (0.44) CDK9CCNT1CCNKCDK14CDK1
SCHEMBL1192549 0.81 CCNT1 (0.46) CDK9CCNT1CCNKCDK14CDK1
SCHEMBL1192293 0.81 CDK9 (0.33) CDK9CCNT1CCNKCDK14CDK1
SCHEMBL15378088 0.80 CDK9 (0.42) CDK9CCNT1MTORCCNKCDK14
SCHEMBL1191733 0.77 AOC2 (0.34) CDK9CCNT1CCNKCDK14CDK1
SCHEMBL12898517 0.77 HSD11B1 (0.36) CDK9CCNT1CCNKCDK14CDK1
SCHEMBL1225997 0.72 ADORA2B (0.35) CCNT1MAP4K4MINK1TNIKMAPT
SCHEMBL1192168 0.72 CCNT1 (0.58) CDK9CCNT1CCNKCDK14CDK1
SCHEMBL1192167 0.72 CCNT1 (0.58) CDK9CCNT1CCNKCDK14CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2668162-A1 SUBSTITUTED BI-HETEROARYL COMPOUNDS AS CDK9 INHIBITORS AND THEIR USES Novartis AG (CH) 2013-12-04 EP disclosed
WO-2012101062-A1 SUBSTITUTED BI-HETEROARYL COMPOUNDS AS CDK9 INHIBITORS AND THEIR USES NOVARTIS AG (CH) 2012-08-02 WO disclosed